SeekingAlpha · Mar 20, 2026
Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors
After years of technology dominance, market leadership appears to be shifting; will it last? Click here to read more.

NYSE · BIS
Financial Services · Asset Management
$11.63
Up+$0.23 (+2.06%)
Updated Nov 20, 2026, 6:26 AM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BIS
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 19, 2026
BIS closed at $11.63 after 21 trading sessions, up 3.79% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | $11.50 | $11.6344 | $11.42 | $11.6344 | 2.76K |
| Nov 18, 2026 | $11.2401 | $11.4041 | $11.1881 | $11.4041 | 2.37K |
| Nov 17, 2026 | $11.27 | $11.43 | $11.19 | $11.2496 | 3.3K |
| Nov 16, 2026 | $10.59 | $11.115 | $10.59 | $11.1091 | 9.58K |
| Nov 13, 2026 | $10.58 | $10.819 | $10.58 | $10.6604 | 2.25K |
| Nov 12, 2026 | $10.24 | $10.5577 | $10.24 | $10.5448 | 22.65K |
| Nov 11, 2026 | $10.175 | $10.27 | $10.0401 | $10.0792 | 6.57K |
| Nov 10, 2026 | $10.0624 | $10.255 | $10.0624 | $10.1599 | 8.36K |
| Nov 9, 2026 | $10.39 | $10.58 | $9.9217 | $9.9964 | 31.61K |
| Nov 6, 2026 | $10.9981 | $10.9981 | $10.53 | $10.5627 | 10.35K |
| Nov 5, 2026 | $10.0201 | $11.04 | $10.0201 | $11.01 | 25.79K |
| Nov 4, 2026 | $10.16 | $10.48 | $10.06 | $10.0663 | 1.69K |
| Nov 3, 2026 | $10.50 | $10.73 | $10.2601 | $10.6197 | 5.36K |
| Nov 2, 2026 | $10.41 | $10.81 | $10.41 | $10.7706 | 21.82K |
| Oct 30, 2026 | $10.41 | $10.55 | $10.06 | $10.4688 | 13.07K |
| Oct 29, 2026 | $10.52 | $10.62 | $10.35 | $10.4648 | 7.97K |
| Oct 28, 2026 | $11.07 | $11.2582 | $10.6472 | $10.6472 | 6.59K |
| Oct 27, 2026 | $11.49 | $11.60 | $10.95 | $10.956 | 10.4K |
| Oct 26, 2026 | $11.42 | $11.51 | $11.27 | $11.3872 | 8.28K |
| Oct 23, 2026 | $11.5099 | $11.56 | $11.36 | $11.4601 | 14.25K |
| Oct 22, 2026 | $11.14 | $11.41 | $10.911 | $11.2097 | 12.45K |
The latest Smart Investors Daily articles mentioning BIS.
Company
Market Activity
Research & News
BIS research
Company profile and research snapshot.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Mar 20, 2026
After years of technology dominance, market leadership appears to be shifting; will it last? Click here to read more.
SeekingAlpha · Mar 6, 2026
SeekingAlpha · Jan 22, 2026
Healthcare stocks were rattled by US policy uncertainty in 2025. But signs of resilience have surfaced as the sector reaffirms its defensive strengths and growth potential.
SeekingAlpha · Jan 8, 2026
After a prolonged slump, investors are giving the healthcare sector a second look. TD Asset Management's Jacky He discusses potential drivers for biotech and pharmaceutical stocks in 2026.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BIS.